Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Bernhard T. Baune, MD, PhD
JCP
Original Research
Celecoxib Augmentation of Vortioxetine for Cognition in MDD
October 4, 2023
Anti-inflammatory augmentation of vortioxetine did not provide additional benefit in reducing cognitive symptoms of MDD.
Emma Sampson
,
Natalie T. Mills
,
Hikaru Hori
, et al
JCP
Original Research
THINC-it and Psychosocial Dysfunction in MDD
November 20, 2018
In your patients with MDD, cognitive deficits may have a greater impact than you realize. This study used the THINC-it assessment to determine the extent to which impaired cognition...
Matthew J. Knight
,
Célia Fourrier
,
Ellen Lyrtzis
, et al
JCP
Original Research
THINC-it Validation for MDD
August 23, 2017
Cognitive dysfunction greatly affects functional outcome in patients with major depressive disorder, but existing tools to measure cognition in depression are inadequate. Read this article to see if the...
Roger S. McIntyre
,
Michael W. Best
,
Christopher R. Bowie
, et al
JCP
Original Research
Clinical Risk Factors for Weight Gain During Psychopharmacologic Treatment of Depression: Results From 2 Large German Observational Studies
June 24, 2015
Stefan Kloiber
,
Katharina Domschke
,
Marcus Ising
, et al
